Amylx Pharmaceuticals Inc vs Bitdeer Technologies Group — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Bitdeer Technologies Group trades at $8.97 (market cap $2.36B). The key difference: Amylx Pharmaceuticals Inc and Bitdeer Technologies Group are close in size by market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Bitdeer Technologies Group nearer its low. Which is the better fit depends on your goals.
| AMLX | BTDR | |
|---|---|---|
Market Cap | $2.64B | $2.36B |
Sector | Health | Technology |
52-Week High | $24.19 | $25.90 |
52-Week Low | $7.82 | $7.28 |
Enterprise Value | $2.39B | $3.85B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Bitdeer is a world-leading technology company for blockchain and high-performance computing. It provides comprehensive digital asset mining solutions, including cloud mining, hosting, and data center management.
Read more on BTDR →